Wegovy and Hair Loss: What Patient Reviews and Evidence Actually Tell Us

What the reviews say, and why telogen effluvium keeps coming up

Scroll through any genuine patient discussion of Wegovy side effects and hair loss will surface within the first few pages. It appears in the Wegovy SmPC as an uncommon but recognised adverse effect, so this is not anecdote running ahead of the evidence. The mechanism, though, is less specific to the drug than people fear. Rapid weight loss places physiological stress on the body: nutrient partitioning shifts, calorie intake drops sharply, and the hair follicle cycle responds by pushing more hairs simultaneously into the resting (telogen) phase. Six to eight weeks later, those hairs shed.

The timing is what catches people off guard. Treatment starts well, weight falls, and then (right when motivation is often highest) there is noticeable hair fall. It can feel alarming, particularly in the shower or when brushing. A wider look at patient experiences with Wegovy's side-effect profile shows this pattern repeated: hair changes appear later than the gastrointestinal effects that get most attention at the start.

None of this means hair loss should be dismissed. It is worth reporting it to your prescriber, monitoring whether it plateaus, and checking that your diet is doing enough work in the background. A prescriber will want to rule out any other contributing factor before attributing it to treatment alone.

What actually drives the shedding: drug, diet or both?

This is the question most reviews cannot answer, but the clinical picture is fairly clear. Semaglutide itself is not a hair toxin. The stronger candidates are the downstream effects of the treatment working: reduced appetite, lower calorie intake, and consequently lower intake of protein, iron, zinc and biotin, all nutrients the follicle cycle depends on.

There is a practical consequence to that finding: how you eat during treatment matters significantly for your hair. Protein adequacy in particular is frequently underestimated. When appetite falls sharply in the first weeks, some people settle into eating patterns that are light enough to widen the nutrient deficit. For a detailed look at how Wegovy side effects such as hair loss develop and what tends to help, that covers what the evidence shows about dietary support and what a prescriber might look at if shedding is significant.

The NHS notes that nausea, vomiting, diarrhoea and constipation are the most common side effects with semaglutide (see the NHS semaglutide medicine page for the full list) and it is these same GI effects that can compress food variety and reduce nutrient intake, creating a compounding pressure on the follicle. Addressing the GI side effects is therefore often part of addressing the hair effects too.

When to get medical help, and what to watch alongside hair changes

Telogen effluvium, while distressing, does not require emergency attention. There are other symptoms that do. Stop treatment and seek urgent help if you develop severe, persistent abdominal pain that radiates to your back: this could indicate acute pancreatitis, a known but rare side effect that the MHRA flagged formally in a January 2026 Drug Safety Update for GLP-1 medicines. Repeated vomiting leading to dehydration, signs of a serious allergic reaction such as swelling of the face or throat, and sudden unexplained changes in mood or thoughts of self-harm all require immediate medical attention.

For hair changes specifically, contact your prescriber if: shedding is worsening rather than plateauing after three to four months; there is patchy or uneven loss rather than generalised thinning; or you notice other skin or nail changes at the same time. These features could point to something other than telogen effluvium, and a clinician should assess them. You can also read more about how wegovy hair loss typically presents, why it happens, and what can be done about it before deciding whether to raise it with your prescriber. You can also report any unexpected reactions via the MHRA Yellow Card scheme, patient reports from real-world use contribute to ongoing safety monitoring of medicines like Wegovy, which still carries a Black Triangle (▼) marking indicating that it is subject to additional scrutiny.

More context on the full side-effect landscape is available in our overview of Wegovy side effects, which covers the GI profile and what to expect at each stage of treatment.

Deciding whether hair loss changes your treatment plan

This is ultimately a clinical decision, made with your prescriber. But here is the honest shape of it. For most people, hair shedding peaks and then gradually slows as weight loss moderates and the body stabilises. Stopping treatment does not reverse the shedding immediately (the follicles will still complete their cycle) and it forfeits the health benefits that prompted treatment in the first place. Continuing treatment, with attention to diet quality and potentially with a blood test to check iron and other levels, is what most prescribers would discuss first.

Some people find practical anchors help: taking a daily supplement with a glass of water alongside their morning routine, for example, or keeping a protein-first approach to meals even when appetite is low. The tablet route does add one extra morning step (swallowing it before the kettle has boiled and waiting at least thirty minutes before anything else) but that kind of routine can also be a useful prompt for a consistent supplement habit.

If you want to read more specifically about what other patients have reported, our analysis of hair loss from Wegovy brings together the common patterns. Alternatively, real-world consumer reports on Wegovy's side effects give a broader view. For anyone weighing up whether Wegovy is still the right option for them, the conversation starts with a prescriber who knows your case. Our clinical team at nume reviews every consultation personally, a real clinician reads your information the same day. If you are ready to discuss suitability, side effects and what to expect, you can speak to our prescribers via a free consultation.